Who
John A. Borgeson
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Kodiak Sciences.
In numbers
- Trades disclosed
- 77
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $5.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Oct 2018
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,500 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,500 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Code M | $31K30,000 at $1.04 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $881K25,896 at $34.01 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $142K4,104 at $34.67 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Code M | $31K30,000 at $1.04 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $881K25,896 at $34.01 | filing |
| 4 Jun 2026filed 5 Jun 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $142K4,104 at $34.67 | filing |
| 15 Apr 2026filed 16 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Code M | $30K28,614 at $1.04 | filing |
| 15 Apr 2026filed 16 Apr 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,614 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,614 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Code M | $30K28,614 at $1.04 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Code M | $31K30,000 at $1.04 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $497K12,692 at $39.14 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $503K12,477 at $40.29 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $173K4,231 at $40.88 | filing |
| 2 Apr 2026filed 2 Apr 2026 | KOD Kodiak SciencesBiotechnology | SEC FORM 4 Sold | $25K600 at $41.77 | filing |
News
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 6.5% – Here's WhyKOD · dailypolitical.com · 19 Oct 2026
0 headlines in the last 90 days name John A. Borgeson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.